AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$18.17
-0.29 (-1.57%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+25.14%
1Y
+121.32%
YTD
+43.52%
Open$18.70
Previous Close$18.46
Day High$18.81
Day Low$17.93
52W High$19.26
52W Low$7.67
Volume—
Avg Volume1.78M
Market Cap5.85B
P/E Ratio47.87
EPS$0.37
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.39
Above
SMA 200
$10.30
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+535.9% upside
Current
$18.17
$18.17
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.97B | 2.67B | 607.96M |
| Net Income | 70.77M | 57.42M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 606.78M | 519.69M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.35 | +1.67% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $257.21 | -0.15% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.63 | +0.23% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $25.98 | +0.64% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $76.68 | +3.07% | 12.1 | 32.02B |